XAGE (Longevity Health Holdings) ROE %: 0.00% (As of Mar. 2026)


XAGE Longevity Health Holdings Inc XAGE
6 GF Score
Price $0.26
! 3 Warning Signs
View Full Analysis

What is Longevity Health Holdings ROE %?

Longevity Health Holdings XAGE -23.30% 6 ROE % is 0.00% as of Mar. 2026. GuruFocus rates XAGE with a GF Score™ of 6/100. The stock has 3 warning signs investors should review. Among 1,914 Consumer Packaged Goods companies, Longevity Health Holdings ranks worse than 52246.55% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Longevity Health Holdings's annualized net income for the quarter that ended in Mar. 2026 was $-5.73 Mil. Longevity Health Holdings's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $-6.38 Mil. Therefore, Longevity Health Holdings's annualized ROE % for the quarter that ended in Mar. 2026 was N/A%.

The historical rank and industry rank for Longevity Health Holdings's ROE % or its related term are showing as below:

XAGE's ROE % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 6.72
* Ranked among companies with meaningful ROE % only.

Longevity Health Holdings  (OTCPK:XAGE) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-5.728/-6.381
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5.728 / 1.568)*(1.568 / 2.0045)*(2.0045 / -6.381)
=Net Margin %*Asset Turnover*Equity Multiplier
=-365.31 %*0.7822*N/A
=ROA %*Equity Multiplier
=-285.75 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-5.728/-6.381
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-5.728 / -5.728) * (-5.728 / -5.312) * (-5.312 / 1.568) * (1.568 / 2.0045) * (2.0045 / -6.381)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1.0783 * -338.78 % * 0.7822 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Longevity Health Holdings ROE % Related Terms


Longevity Health Holdings ROE % Historical Data

* Premium members only.

The historical data trend for Longevity Health Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Health Holdings ROE % Chart

Longevity Health Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
0.00 0.00 0.00 -103.49 0.00

Longevity Health Holdings Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XAGE vs SNBH, SKVI, PG: ROE % Comparison

For the Household & Personal Products subindustry, Longevity Health Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Health Holdings ROE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Longevity Health Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Longevity Health Holdings's ROE % falls into.


XAGE
6GF Score
Longevity Health Holdings Inc XAGE
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Longevity Health Holdings ROE % Calculation

Longevity Health Holdings's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-6.905/( (-4.713+-5.867)/ 2 )
=-6.905/-5.29
=N/A %

Longevity Health Holdings's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-5.728/( (-5.867+-6.895)/ 2 )
=-5.728/-6.381
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
Longevity Health Holdings (XAGE) has a ROE % of 0.00% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Longevity Health Holdings and its competitors. According to the industry distribution chart, Longevity Health Holdings ranks #999999 out of 1914 companies in the Consumer Packaged Goods industry.
Is Longevity Health Holdings' ROE % too high?
Longevity Health Holdings' current ROE % is 0.00%. Based on the distribution chart, Longevity Health Holdings ranks #999999 out of 1914 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Longevity Health Holdings has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Longevity Health Holdings' ROE % compare to SNBH and SKVI?
According to the Consumer Packaged Goods industry distribution chart, Longevity Health Holdings ranks #999999 out of 1914 companies for ROE %. This places Longevity Health Holdings in the lower half of its industry. The industry median ROE % is 6.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.72, based on 1,914 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Longevity Health Holdings and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Health Holdings's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Health Holdings stock overvalued right now?
Longevity Health Holdings (XAGE) has a current ROE % of 0.00%. The current ROE % is 0.00%. Longevity Health Holdings' overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Longevity Health Holdings (XAGE), the current ROE % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Health Holdings Business Description

Address 2403 Sidney Street, Suite 300, Pittsburgh, PA, USA, 15203
Longevity Health Holdings Inc is a bio-aesthetics company focused on longevity and healthy aging. The company develops cosmetic skincare and haircare products designed to support skin and hair health, tailored to meet the technical requirements of professional care providers as well as retail consumers. Its product pipeline also includes regenerative bone and tissue healing solutions, although further research and development in this area has been paused. The company markets its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor sales channels.
6GF Score

Get the complete analysis for XAGE

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price